VOX SANGUINIS

Scope & Guideline

A Voice for Groundbreaking Hematological Discoveries

Introduction

Delve into the academic richness of VOX SANGUINIS with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0042-9007
PublisherWILEY
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Converge1952, 1954, from 1956 to 2024
AbbreviationVOX SANG / Vox Sang.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

VOX SANGUINIS focuses on the field of transfusion medicine and blood safety, highlighting the latest research, innovations, and practices to enhance blood donation, transfusion safety, and patient care. The journal aims to provide a platform for disseminating knowledge and fostering collaboration among professionals in the field.
  1. Transfusion Safety and Efficacy:
    Research on practices and technologies that enhance the safety and effectiveness of blood transfusions, including pathogen reduction methods and risk assessment strategies.
  2. Blood Donation Policies and Practices:
    Exploration of donor eligibility criteria, recruitment strategies, and the impact of societal factors on blood donation rates and donor behavior.
  3. Immunohematology and Blood Group Genetics:
    Investigation into blood group antigens, genotyping, and their implications for transfusion compatibility and patient outcomes.
  4. Patient Blood Management:
    Studies aimed at optimizing transfusion practices and reducing unnecessary blood use, focusing on patient-centered care and outcomes.
  5. Infectious Disease Monitoring:
    Research on the prevalence of transfusion-transmitted infections and the effectiveness of screening methods to ensure blood safety.
  6. Quality Improvement in Blood Services:
    Development and implementation of quality improvement initiatives within blood services to enhance operational efficiency and donor safety.
  7. Emerging Therapies and Technologies:
    Investigation of novel therapies, including convalescent plasma and gene therapy, and their role in transfusion medicine.
The recent publications in VOX SANGUINIS demonstrate a clear shift towards addressing contemporary challenges and innovations in transfusion medicine. These emerging themes reflect the journal's responsiveness to global health trends and advancements in technology.
  1. Impact of COVID-19 on Blood Services:
    A surge in research related to how the COVID-19 pandemic has affected blood donation rates, transfusion practices, and donor safety, highlighting the need for adaptive strategies in crisis situations.
  2. Diversity and Inclusivity in Blood Donation:
    Increased focus on improving inclusivity for diverse donor populations, including LGBTQ+ individuals, and addressing barriers to donation, indicating a broader societal awareness of equity in healthcare.
  3. Advancements in Pathogen Reduction Technologies:
    Emerging studies on novel pathogen reduction strategies and their implications for enhancing blood safety, reflecting ongoing technological innovations in the field.
  4. Use of Machine Learning and Data Analytics:
    Growing interest in employing machine learning and data analytics to predict transfusion outcomes and improve donor management, indicative of a trend towards data-driven decision-making.
  5. Patient-Centric Transfusion Strategies:
    Research emphasizing patient blood management and individualized care in transfusion practices, showcasing a shift towards patient-centered approaches in transfusion medicine.
  6. Ethical Considerations in Blood Donation:
    Emerging discussions around ethical issues related to blood donation, particularly in the context of new therapies and vulnerable populations, highlighting the importance of ethical frameworks in practice.

Declining or Waning

While VOX SANGUINIS continues to cover a broad range of topics, certain themes appear to be diminishing in frequency or focus in recent publications. This decline may reflect evolving priorities within the field of transfusion medicine and changing societal contexts.
  1. Traditional Blood Transfusion Practices:
    Research on standard transfusion practices is becoming less prevalent as newer, evidence-based approaches are developed and adopted, indicating a shift towards more innovative and patient-centered care.
  2. Historical Perspectives on Transfusion Medicine:
    Papers focused on historical analyses of transfusion practices and policies are appearing less frequently, suggesting a move towards contemporary issues and future directions in the field.
  3. Generalized Risk Factors for Blood Donation:
    Studies examining broad, non-specific risk factors for blood donation are decreasing as more targeted research on specific populations and conditions emerges.
  4. Simple Blood Component Utilization Studies:
    Basic descriptive studies on blood component utilization without in-depth analysis or innovative methods are less common, indicating a preference for more complex, data-driven studies.

Similar Journals

JOURNAL OF CLINICAL PATHOLOGY

Connecting Evidence to Effective Treatment
Publisher: BMJ PUBLISHING GROUPISSN: 0021-9746Frequency: 12 issues/year

JOURNAL OF CLINICAL PATHOLOGY, published by BMJ PUBLISHING GROUP, stands at the forefront of advancements in the field of clinical pathology, offering a platform for groundbreaking research and insights from 1948 to the present. With an impressive impact factor and categorized as Q1 in both Medicine (miscellaneous) and Pathology and Forensic Medicine for 2023, the journal holds a distinguished position in the academic community, ranking 22nd out of 208 journals in its category on Scopus and representing the 89th percentile. While the journal does not currently offer open access, it remains a vital resource for researchers, healthcare professionals, and students seeking to stay current with innovative methodologies, clinical techniques, and diagnostic advancements. Located in London, United Kingdom, the journal aims to bridge the gap between laboratory findings and clinical practice, emphasizing the importance of evidence-based pathology in improving patient care and treatment outcomes. Engage with the JOURNAL OF CLINICAL PATHOLOGY to enhance your understanding and contribute to the evolving landscape of clinical pathology research.

BLOOD PURIFICATION

Elevating Standards in Blood Purification Practices.
Publisher: KARGERISSN: 0253-5068Frequency: 12 issues/year

BLOOD PURIFICATION is a distinguished peer-reviewed journal published by KARGER, recognized for its in-depth exploration of the interdisciplinary topics surrounding blood purification technologies and techniques, encompassing nephrology and hematology. Since its inception in 1983, this reputable journal has provided a vital platform for disseminating groundbreaking research, reviews, and clinical practices aimed at advancing the understanding and management of blood-related conditions. With an impressive impact factor positioned within the second quartile (Q2) in the fields of Hematology, Nephrology, and Miscellaneous Medicine (2023), BLOOD PURIFICATION is highly regarded among researchers and professionals dedicated to enhancing patient outcomes. The journal aims to foster a collaborative academic environment, sharing innovative findings and methodologies, making it an essential resource for scholars, clinicians, and students alike. This publication does not currently offer Open Access options, and is based in Switzerland, with its editorial office located at Allschwilerstrasse 10, CH-4009 Basel. Engage with BLOOD PURIFICATION to stay at the forefront of advancements in blood purification science.

TRANSFUSION AND APHERESIS SCIENCE

Empowering Research for Enhanced Patient Outcomes in Hematology
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 1473-0502Frequency: 6 issues/year

TRANSFUSION AND APHERESIS SCIENCE, published by Pergamon-Elsevier Science Ltd, serves as a pivotal platform for researchers and practitioners in the fields of hematology, transfusion medicine, and apheresis. With an ISSN of 1473-0502 and an E-ISSN of 1878-1683, this peer-reviewed journal boasts a respectable Q3 ranking in the Hematology category as of 2023, positioning it within the 45th percentile among its counterparts. Operating from the United Kingdom, it provides comprehensive insights into the latest advancements and methodologies in transfusion practices and apheresis technology, crucial for enhancing patient care and therapeutic strategies. The journal's scope, covering key developments from 1996 to 2024, allows for a deep exploration of historical and emerging trends within the discipline. Moreover, its open access options facilitate widespread dissemination of research findings, fostering collaboration and innovation in the scientific community. For those dedicated to advancing knowledge in hematology, TRANSFUSION AND APHERESIS SCIENCE represents an essential resource, bridging theory and practice in this vital area of healthcare.

Journal of Blood Medicine

Elevating Standards: The Premier Source for Blood Medicine Insights
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-2736Frequency: 1 issue/year

The Journal of Blood Medicine, published by DOVE MEDICAL PRESS LTD, stands as a vital resource in the field of hematology, focusing on the latest research developments and clinical advancements in blood medicine. With an impact factor reflective of its growing relevance, this open-access journal has been delivering quality scholarly work since 2010, ensuring that critical research is readily available to the global scientific community. The journal operates under an open-access model, further enhancing its dissemination and accessibility to researchers, professionals, and students alike. In the 2023 rankings, it secured a Q3 category status within hematology and achieved a commendable 76th rank out of 137 in Scopus listings, indicating its commitment to quality and innovation in this specialized area. Located in New Zealand, the journal's diverse topics encompass clinical research, treatment modalities, and emerging therapies, contributing significant insights vital for shaping future advancements in blood medicine.

Hematology-American Society of Hematology Education Program

Advancing Hematology through Expert Education
Publisher: AMER SOC HEMATOLOGYISSN: 1520-4391Frequency: 1 issue/year

Hematology-American Society of Hematology Education Program is a premier peer-reviewed journal dedicated to advancing the field of hematology through comprehensive educational content. Published by the American Society of Hematology, this journal plays a crucial role in disseminating knowledge to researchers, clinicians, and students in hematology and related disciplines. With an impressive Q1 status in the field, it ranks among the top journals at the forefront of hematological research, as evidenced by its 60th percentile ranking in Scopus' Medicine - Hematology category. Although it does not offer open access, the journal provides invaluable insights and educational resources from leading experts, focusing on the latest advancements, treatment protocols, and evolving understanding of blood disorders. Covering a wide range of topics, from basic research to clinical applications, this journal is essential for anyone seeking to deepen their expertise and stay informed on the latest developments in hematology. For further engagement, readers can access insightful articles published since 2001, ensuring a rich repository of knowledge for ongoing research and clinical excellence.

Blood Transfusion

Empowering Research in Hematology and Immunology.
Publisher: SIMTIPRO SRLISSN: 1723-2007Frequency: 6 issues/year

Blood Transfusion is a leading journal in the fields of Hematology, Immunology, and Medicine, published by SIMTIPRO SRL in Italy. With its ISSN 1723-2007, the journal has established a significant presence in the academic community, as evidenced by its positioning within the Q2 category in Hematology and Medicine (miscellaneous) and Q3 in Immunology and Allergy for 2023. Notably, it ranks #38 out of 137 in the Hematology category, showcasing its impactful contributions to research and practice. Operating under a traditional publishing model, this journal provides valuable insights into advances in blood transfusion science, ultimately aimed at enhancing patient care and outcomes. Spanning from 2003 to 2024, the scope of Blood Transfusion covers a wide range of topics related to hematological and immunological research, making it an essential resource for researchers, healthcare professionals, and students engaged in these critical fields.

Hematology Transfusion and Cell Therapy

Innovating the future of blood disorder management.
Publisher: ELSEVIERISSN: 2531-1379Frequency: 4 issues/year

Hematology Transfusion and Cell Therapy, published by Elsevier, is a leading Open Access journal dedicated to advancing the fields of hematology, immunology, and transfusion medicine. Since its establishment in 2018, this journal has provided a vital platform for sharing innovative research and clinical advancements in the management of blood disorders and cellular therapies. Based in Brazil, it attracts a global audience, facilitating access to high-quality research that influences clinical practice and policy. With a current impact factor that places it in the Q3 category for both hematology and immunology as of 2023, the journal is recognized for its rigorous peer-review process and commitment to disseminating significant findings. By featuring a diverse range of articles, from original research to reviews, Hematology Transfusion and Cell Therapy aims to foster collaboration and knowledge sharing among researchers, professionals, and students alike, empowering them to tackle emerging challenges in their fields.

TRANSFUSION MEDICINE AND HEMOTHERAPY

Advancing transfusion science for better patient outcomes.
Publisher: KARGERISSN: 1660-3796Frequency: 6 issues/year

TRANSFUSION MEDICINE AND HEMOTHERAPY, published by KARGER, is a prominent journal dedicated to advancing the fields of hematology and transfusion medicine. With an ISSN of 1660-3796 and E-ISSN 1660-3818, this esteemed journal has been a valuable resource for researchers and clinicians since its inception in 1973, with significant publication phases continuing into 2024. It currently holds a Q2 ranking in Hematology and a Q3 ranking in Immunology and Allergy, reflecting its impact and relevance in these critical fields. The journal features original articles, reviews, and clinical studies, presenting cutting-edge research that aids in the development of effective therapies and enhances patient care. Open access options are available, ensuring that crucial findings are accessible to a broad audience. As an important platform for dialogue and advancement in transfusion science, TRANSFUSION MEDICINE AND HEMOTHERAPY supports the global health community's efforts to improve treatment outcomes and foster innovation in medical practices.

Blood and Lymphatic Cancer-Targets and Therapy

Transforming Cancer Treatment Through Open Access
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-9889Frequency: 1 issue/year

Blood and Lymphatic Cancer-Targets and Therapy, published by DOVE MEDICAL PRESS LTD, is a vital open-access journal that has been disseminating crucial research and findings in the field of hematology and oncology since 2011. With its ISSN 1179-9889, this journal focuses on the latest therapeutic targets and innovative treatment strategies for blood and lymphatic cancers, contributing significantly to the advancement of knowledge and practice in this specialized area. Designed for researchers, healthcare professionals, and students alike, Blood and Lymphatic Cancer-Targets and Therapy aims to foster a deeper understanding of cancer biology and promote collaborative efforts leading to novel therapeutic interventions. The open-access model ensures that research findings are readily accessible to a global audience, underscoring the journal's commitment to enhancing patient care and fostering educational growth in the cancer domain.

Blood Research

Illuminating the Path in Blood Research and Patient Care
Publisher: SPRINGERISSN: 2287-979XFrequency: 4 issues/year

Blood Research, published by SPRINGER, is a premier journal dedicated to the multifaceted realm of hematology, serving as a crucial platform for disseminating innovative research findings and advancements in the diagnosis and treatment of blood-related disorders. With an ISSN of 2287-979X and an E-ISSN of 2288-0011, this journal is recognized for its commitment to scholarly excellence and impact in the field, currently holding a reputable Q2 ranking in the Hematology category as per the 2023 metrics. The journal spans from 2013 to 2024, providing a broad archive of quality research that is vital for researchers, healthcare professionals, and students alike. Although it is not an Open Access journal, it offers insightful contributions that enhance the understanding of hematological science, fostering the exchange of knowledge crucial for advancing patient care and clinical practices globally. The journal’s performance is underscored by its Scopus ranking in the 46th percentile, reflecting its significant role in the ongoing discourse in hematology.